NARA Discovery
Article Details
← Back to Search Results
Journal Article

SARS-CoV-2 Infects Red Blood Cell Progenitors and Dysregulates Hemoglobin and Iron Metabolism

Romy Kronstein-Wiedemann; Marlena Stadtmüller; Sofia Traikov; Mandy Georgi; Madeleine Teichert; Hesham Yosef; Jan Wallenborn; Andreas Karl; Karin Schütze; Michael Wagner; Ali El-Armouche; Torsten Tonn
Stem Cell Reviews and Reports · Vol. 18, Issue 5 · pp. 1809-1821 · 2022

Abstract

Background SARS-CoV-2 infection causes acute respiratory distress, which may progress to multiorgan failure and death. Severe COVID-19 disease is accompanied by reduced erythrocyte turnover, low hemoglobin levels along with increased total bilirubin and ferritin serum concentrations. Moreover, expansion of erythroid progenitors in peripheral blood together with hypoxia, anemia, and coagulopathies highly correlates with severity and mortality. We demonstrate that SARS-CoV-2 directly infects erythroid precursor cells, impairs hemoglobin homeostasis and aggravates COVID-19 disease. Methods Erythroid precursor cells derived from peripheral CD34+ blood stem cells of healthy donors were infected in vitro with SARS-CoV-2 alpha variant and differentiated into red blood cells (RBCs). Hemoglobin and iron metabolism in hospitalized COVID-19 patients and controls were analyzed in plasma-depleted whole blood samples. Raman trapping spectroscopy rapidly identified diseased cells. Results RBC precursors express ACE2 receptor and CD147 at day 5 of differentiation, which makes them susceptible to SARS-CoV-2 infection. qPCR analysis of differentiated RBCs revealed increased HAMP mRNA expression levels, encoding for hepcidin, which inhibits iron uptake. COVID-19 patients showed impaired hemoglobin biosynthesis, enhanced formation of zinc-protoporphyrine IX, heme-CO 2 , and CO-hemoglobin as well as degradation of Fe-heme. Moreover, significant iron dysmetablolism with high serum ferritin and low serum iron and transferrin levels occurred, explaining disturbances of oxygen-binding capacity in severely ill COVID-19 patients. Conclusions Our data identify RBC precursors as a direct target of SARS-CoV-2 and suggest that SARS-CoV-2 induced dysregulation in hemoglobin- and iron-metabolism contributes to the severe systemic course of COVID-19. This opens the door for new diagnostic and therapeutic strategies. Graphical Abstract

Bibliographic Information

JournalStem Cell Reviews and Reports
PublisherSpringer
Publication Date2022-06-01
Publication Year2022
Volume18
Issue5
Pages1809-1821
Document TypeJournal Article
Print ISSN2629-3269
eISSN2629-3277
DOI10.1007/s12015-021-10322-8

Access Information

NARA Access Coverage2005-01-01~Current
Journal Homepagehttps://www.springer.com/journal/12015
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.